Industry in brief | Pierre Fabre, Beiersdorf, RB, P&G

Industry in brief | Pierre Fabre, Beiersdorf, RB, P&G

20 March 2020 - Deborah Wilkes

In response to the COVID-19 pandemic, Pierre Fabre is starting to manufacture hydroalcoholic gels, Beiersdorf has stepped up production of medical grade disinfectants, RB has launched a public health information campaign, and Procter & Gamble’s (P&G’s) Vicks brand has donated USD1 million to a medical relief organisation.

Pierre Fabre to make hydroalcoholic gels

France’s Pierre Fabre is to start manufacturing hydroalcoholic gels for dispensing pharmacies amid the COVID-19 pandemic.

Noting there was a risk of shortages, Pierre Fabre commented that French pharmacists and pharmacy staff needed supplies of the gels to protect themselves as they carried out their jobs and to meet the huge demand from their patients.

Pierre Fabre said production was expected to start around 25 March 2020. The hydroalcoholic gel would be sold in pharmacies as part of the Ducray skincare brand, added the company, noting that it would be available at the recommended retail price fixed by the French government – not more than EUR3.00 (USD3.20) for a 100ml bottle.

Pierre Fabre said it had reconfigured a production line generally reserved for shampoos, was using 100ml bottles that normally contained Klorane products and was having 600,000 labels printed.

Beiersdorf steps up production

Beiersdorf said it had stepped up production of medical grade disinfectants within its European production network to support the fight against the COVID-19 pandemic.

The German skincare specialist is providing 500 tons of the medical hand sanitisers to critical public emergency services and personnel. The sanitisers are produced in its production plants in Hamburg, Germany, and Madrid, Spain.

Beiersdorf said initial distribution was primarily to clinics and hospitals; medical and nursing staff; and other public services.

RB launches public health information campaign

RB’s Dettol and Lysol brands have launched a public health information campaign to tackle false information about the COVID-19 pandemic.

The company said a new website at aimed to provide authoritative and science-based comment on topics such as the transmission of the virus, misinformation about cures, and methods to mitigate and protect.

RB said it would assess and evaluate claims related to COVID-19, correct misinformation, challenge misperceptions and debunk common myths. The company added that it was using “trusted expert sources from the Economist Intelligence Unit and public health experts to analyse the evidence for and against claims and, where applicable, call out unsubstantiated or incorrect information”.

The company said it had also donated products and funds worth GBP5.50 million (USD6.35 million) to relevant healthcare authorities and non-governmental organisations (NGOs) in China.

Vicks donates USD1 million to Direct Relief

P&G’s Vicks family of cold and flu brands is responding to the COVID-19 pandemic by donating USD1 million to Direct Relief, one of the world’s largest medical relief organisations.

The funds will go towards equipping front line health workers with protective gear and providing medicines and equipment needed to treat an anticipated spike in ICU patients. Direct Relief is also working to expand medical assistance to safety-net health facilities where chronic gaps are expected to widen.

“As a leader in consumer health for more than 125 years, Vicks has always focused on providing care and promoting relief in times of need,” said Paul Gama, president-elect, Global P&G Personal Health Care. “This time is no different – we must come together to help those most in need.”

Click tags below for more information on topics:

Pierre Fabre Beiersdorf RB Procter & Gamble

Back to Industry News

Share this page: